COVID-19 Treatment FAQ

Frequently Asked Questions (FAQ's) About COVID-19 Treatment

Waianae Coast Comprehensive Health Center (WCCHC) recently began treating COVID-19 positive patients with Monoclonal Antibody Therapy. Monoclonal Antibody (MOAB) Therapy is approved by the Food and Drug Administration (FDA) for Emergency Use Authorization (EUA). This service provides immediate COVID-19 treatment for certain individuals that fall within specific high-risk criteria. This one-time treatment works by providing a high dose of antibodies to help prevent severe illnesses that would require hospitalization. Monoclonal antibodies have been used for decades to treat a variety of illnesses including rheumatoid arthritis and cancer.

Monoclonal Antibody therapy is NOT a substitute for the COVID-19 vaccination. COVID-19 vaccines are the safest, most effective way to prevent severe illness and death against all variants.

Criteria for Monoclonal Antibody Treatment:

  • ONLY SOME PEOPLE ARE ELIGIBLE FOR MOAB THERAPY, but all people 12 and older are eligible to be vaccinated
  • MOAB THERAPY IS AUTHORIZED FOR INDIVIDUALS 12 & OLDER WITH MILD TO MODERATE COVID-19 who are at risk for severe illness, not hospitalized and who do not require supplemental oxygen or an increase in home oxygen therapy
  • MOAB THERAPY PROVIDES A SHORT BURST OF IMMUNITY compared to the longer-lasting immunity created by the vaccination
  • TREATMENT WITH MOAB WITHIN THE FIRST 10 DAYS OF SYMPTOMS could reduce the risk of severe illness, hospitalization and death
  • IF YOU RECEIVED MOAB THERAPY & WOULD LIKE TO GET VACCINATED there will be a 90 day waiting period before you can receive the vaccine
  • PATIENTS MUST BE REFERRED BY A PROVIDER FOR THE MOAB TREATMENT Ask your provider if you are interested in getting MOAB therapy for COVID-19

To learn more, visit
Watch their informative video at